VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.Muller, Y.A., Chen, Y., Christinger, H.W., Li, B., Cunningham, B.C., Lowman, H.B., de Vos, A.M.
(1998) Structure 6: 1153-1167
- PubMed: 9753694
- DOI: https://doi.org/10.1016/s0969-2126(98)00116-6
- Primary Citation of Related Structures:
- PubMed Abstract:
Vascular endothelial growth factor (VEGF) is a highly specific angiogenic growth factor; anti-angiogenic treatment through inhibition of receptor activation by VEGF might have important therapeutic applications in diseases such as diabetic retinopathy and cancer. A neutralizing anti-VEGF antibody shown to suppress tumor growth in an in vivo murine model has been used as the basis for production of a humanized version.
Department of Protein Engineering Genentech, Inc. 1 DNA Way, South San Francisco, CA 94080, USA.